TrialPediatric diabetes2022

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes.

Margarita Barrientos-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.